Published within
|«
«
|
...
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
...
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
Market Product Forecasts for currently marketed targeted cancer therapies including; an overview of sales in each of the seven major pharmaceutical markets and sales forecasts for each brand over the forecast period 2011-21.
Published By Datamonitor
|
20 Jul 2012 |
$6400
|
Report
|
This report and accompanying deliverable provides forecasts for HER2-/HR+ breast cancer drugs in the seven major markets from 2011-20. Including in-depth analysis of the market in individual countries and molecule dynamics of the key therapies.
Published By Datamonitor
|
19 Jul 2012 |
$6400
|
Report
|
Overview of asthma disease definition and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year case forecast, and key patient segments across the seven major markets.
Published By Datamonitor
|
18 Jul 2012 |
$2800
|
Report
|
This report analyses key marketed and pipeline drugs for melanoma. This includes assessment of current and future market strength of approved drugs, key drug development strategies, and commercial and clinical potential of pipeline drugs.
Published By Datamonitor
|
18 Jul 2012 |
$2800
|
Report
|
This report provides an analysis of strategies and trends employed by companies operating in the in vitro diagnostics (IVDs) market in order to drive revenue growth.
Published By Datamonitor
|
17 Jul 2012 |
$2800
|
Report
|
Overview of targeted cancer therapies and biomarkers, with in-depth analysis of drug and companion diagnostic development, commercial potential, role of regulatory authorities in the seven major markets and key pipeline personalized cancer therapies.
Published By Datamonitor
|
16 Jul 2012 |
$1520
|
Report
|
Assessment of the current and future schizophrenia market using a patient-based forecasting methodology. The analysis is designed to understand the future dynamics of the schizophrenia drug market, with a particular focus on pipeline therapies.
Published By Datamonitor
|
13 Jul 2012 |
$6400
|
Report
|
In-depth analysis of key brands and pipeline candidates for inflammatory bowel disease, including a review of new clinical data and a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
29 Jun 2012 |
$6400
|
Report
|
Overview of asthma prevalence in China and a review of epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year prevalent case forecast, and key patient segments across the seven major markets.
Published By Datamonitor
|
28 Jun 2012 |
$4800
|
Report
|
This report analyzes the unmet needs of schizophrenia treatment and the attributes of drugs that influence the prescribing decisions made by physicians across the seven major markets.
Published By Datamonitor
|
26 Jun 2012 |
$2800
|
|«
«
|
...
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
...
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.